Suppr超能文献

乳腺癌既往磁共振成像假阴性结果分析。

Analysis of false-negative findings of breast cancer on previous magnetic resonance imaging.

机构信息

Department of Radiology, Research Institute of Radiology, 65526Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.

出版信息

Acta Radiol. 2021 Jun;62(6):722-734. doi: 10.1177/0284185120941830. Epub 2020 Jul 19.

Abstract

BACKGROUND

Despite the excellent contribution of contrast-enhanced breast magnetic resonance imaging (MRI), there are variable false-negative cases on MRI.

PURPOSE

To evaluate the false-negative findings of breast cancer on previous MRI.

MATERIAL AND METHODS

Between 2012 and 2016, we collected 132 patients who underwent surgery for a second primary cancer and had both current and previous MRI at an interval of <3 years. We included 45 patients; we excluded 38 patients who could not find a second cancer in the previous MRI and 49 patients who had a second cancer near to the original cancer and within within the same quadrant. Compared with current MRI, we retrospectively assessed the second primary cancer on previous MRI according to BI-RADS and analyzed the reasons of misinterpretation.

RESULTS

Analysis of previous MRI revealed 26 (57.8%) masses (mean size 7.7 ± 2.25 mm), 12 (26.7%) non-mass enhancements (mean size 14.7 ± 4.76 mm), and 7 (15.5%) foci. At first reading, 24 (53.3%) were missed, 17 (37.8%) were assessed as BI-RADS category 2 or 3, and 4 (8.9%) were assessed as category 4. On current MRI, 39 (86.7%) lesions showed an increase in size and 22 (48.9%) showed a change in kinetics to wash-out pattern.

CONCLUSION

On previous MRI, missed or misinterpreted cancers show variable findings of mass and non-mass enhancements with any types of kinetics. Careful application of BI-RADS is necessary as well as an appropriate biopsy. Any lesion that increases in size and changes in kinetics should not be underestimated.

摘要

背景

尽管对比增强乳腺磁共振成像(MRI)贡献卓越,但 MRI 仍存在一些假阴性病例。

目的

评估既往 MRI 中乳腺癌的假阴性结果。

材料与方法

在 2012 年至 2016 年间,我们收集了 132 例因第二原发癌而行手术且在 3 年内有当前和既往 MRI 的患者。我们纳入了 45 例患者;排除了 38 例在既往 MRI 中找不到第二原发癌的患者,以及 49 例第二原发癌位于原癌附近且位于同一象限内的患者。与当前 MRI 相比,我们回顾性地根据 BI-RADS 评估了既往 MRI 中的第二原发癌,并分析了误诊的原因。

结果

对既往 MRI 的分析显示 26 例(57.8%)为肿块(平均大小 7.7±2.25mm),12 例(26.7%)为非肿块样强化(平均大小 14.7±4.76mm),7 例(15.5%)为局灶性病变。初次阅读时,24 例(53.3%)被漏诊,17 例(37.8%)评估为 BI-RADS 类别 2 或 3,4 例(8.9%)评估为类别 4。在当前 MRI 上,39 例(86.7%)病变显示大小增加,22 例(48.9%)显示动力学变化为洗脱模式。

结论

既往 MRI 中漏诊或误诊的癌症表现为肿块和非肿块强化的各种表现,具有任何类型的动力学。有必要仔细应用 BI-RADS 并进行适当的活检。任何大小增加和动力学改变的病变都不应被低估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验